CDH1 hypermethylation: A potential molecular pathway for invasiveness in glioblastoma

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (UNESP)-
Autor(es): dc.creatorBelut, Daniel R.-
Autor(es): dc.creatorLima, Estela De O.-
Autor(es): dc.creatorZanini, Marco A.-
Autor(es): dc.creatorGalvani, Aline F.-
Autor(es): dc.creatorFurtado, Fabiana B.-
Autor(es): dc.creatorFerrasi, Adriana C.-
Data de aceite: dc.date.accessioned2025-08-21T21:28:29Z-
Data de disponibilização: dc.date.available2025-08-21T21:28:29Z-
Data de envio: dc.date.issued2025-04-29-
Data de envio: dc.date.issued2023-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1097/CEJ.0000000000000824-
Fonte completa do material: dc.identifierhttps://hdl.handle.net/11449/296965-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/296965-
Descrição: dc.descriptionGlioblastoma is the most aggressive central nervous system primary tumor. Prognosis is poor, mainly due to the malignant characteristics of the tumor, such as high cell proliferation and invasiveness. CDH1 hypermethylation is linked to the invasive potential in various cancer types, but its importance is still unknown in glioblastoma. In this context, the methylation status of CDH1 was analyzed using MSP-PCR (Methylation-specific Polymerase Chain Reaction) in glioblastoma (n = 34) and normal glial tissue samples (n = 11). CDH1 hypermethylation was found in 39.4% (13/34) of the tumor samples and none of the normal glial tissue, suggesting a relation between CDH1 hypermethylation and glioblastoma (P = 0.0195). Finally, this study showed unprecedented information that could contribute to clarifying the molecular pathways involved in the invasiveness and aggressiveness of this type of cancer.-
Descrição: dc.descriptionDepartment of Internal Medicine Botucatu Medical School UNESP Sao Paulo State University-
Descrição: dc.descriptionDepartment of Neurology Psychology and Psychiatry Botucatu Medical School UNESP Sao Paulo State University-
Descrição: dc.descriptionLaboratory of Applied Biotechnology Brazil Clinical Hospital of Botucatu Medical School (HCFMB) Sao Paulo State University (UNESP)-
Descrição: dc.descriptionDepartment of Internal Medicine Botucatu Medical School UNESP Sao Paulo State University-
Descrição: dc.descriptionDepartment of Neurology Psychology and Psychiatry Botucatu Medical School UNESP Sao Paulo State University-
Descrição: dc.descriptionLaboratory of Applied Biotechnology Brazil Clinical Hospital of Botucatu Medical School (HCFMB) Sao Paulo State University (UNESP)-
Formato: dc.format73-75-
Idioma: dc.languageen-
Relação: dc.relationEuropean Journal of Cancer Prevention-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectCadherin-1-
Palavras-chave: dc.subjectCDH1-
Palavras-chave: dc.subjectcentral nervous system-
Palavras-chave: dc.subjectglioblastoma-
Palavras-chave: dc.subjectmethylation-
Título: dc.titleCDH1 hypermethylation: A potential molecular pathway for invasiveness in glioblastoma-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.